Skip to main content

Table 1 Participant timeline

From: Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial

 Study phase
ScreeningAllocationInterventionFollow-up
Time point (weeks)–20481216
Enrollment
EligibilityX     
Informed consentX     
Allocation X    
Intervention
SLGD  XXX 
LLGD  XXX 
Placebo  XXX 
Assessment
Demographic indexesXX    
HOMA-IR XX XX
Hepatic function XX XX
Lipid metabolism XX XX
Glucose metabolism XX XX
Inflammation response XX XX
Liver-kidney echo ratio X  X 
Body measurements XXXXX
TCM pattern scale XXXXX
SF-36 X  XX
SAS X  XX
SDS X  XX
Vital signs XXXXX
Blood routine test XX XX
Electrocardiograph XX X 
AEs XXXXX
Biological sample collection XX XX
  1. AE adverse event, LLGD low dose Lingguizhugan decoction, SLGD standard dose Lingguizhugan decoction